Eli Lilly Allowed to Join Weight Loss Drug Compounding Lawsuit

A federal judge in Texas is allowing Eli Lilly & Co. to intervene in a legal battle between the FDA and drug compounders over whether the company’s blockbuster diabetes and weight loss drug tirzepatide is in short supply.

Judge Mark T. Pittman for the US District Court for the Northern District of Texas found that good cause exists for Lilly’s intervention, according to an order Monday granting the company’s motion to intervene.

Lilly requested on Jan. 1 to join a lawsuit brought by the Outsourcing Facilities Association and compounding pharmacy FarmaKeio Custom Compounding challenging the Food and Drug Administration’s October ...